Reports
Sale
Global Digiceuticals Market Size, Trends, Research, Demand, Report: By Type: Software, Devices; By Application: Mental Health, Chronic Disease Management, Medication Adherence, Others; By End User: Hospital, Specialty Clinics; Market Dynamics; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032
Global Digiceuticals Market Outlook
The global digiceuticals market size was valued at USD 6.10 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 32.5% during the forecast period of 2024-2032 to achieve a value of USD 76.72 billion by 2032.
Digiceuticals: Introduction
The use of digital technologies in healthcare has revolutionized patient care. The concept of "Digiceuticals" encompasses a range of tools and services, including mobile applications, wellness assessments, and trackers. These tools are designed to monitor and enhance the effects of medications on the body's physiology, ultimately leading to better patient outcomes.
In today's world, the use of digiceuticals is just as important as the actual medications themselves as they provide valuable insights into the patient's health and help healthcare providers make better-informed decisions.
Global Digiceuticals Market Analysis
The market for digital therapeutics, or digiceuticals, is witnessing rapid growth due to the widespread use of smartphones, mobile apps, and partnerships between technology and pharmaceutical companies. The rise in public awareness of smart health tracking is also contributing to this growth.
Digiceuticals uses modern technologies, such as data analytics, AI, blockchain, and machine learning, to help pharmaceutical companies increase their revenue, cut costs, and improve treatment outcomes, propelling the global digiceuticals market growth further.
For example, automation can speed up drug development and blockchain can protect intellectual property and ensure transparency. Personalized medicine is also a potential use case, using genomic data and patient health records to create targeted drugs at a lower cost.
The growth of the market is further driven by collaborations between pharma and digiceutical companies for various clinical conditions. Regulatory approvals and clearances for digital therapeutic solutions are also increasing, indicating their clinical robustness and acceptance by regulatory bodies. Clinical studies are validating the effectiveness of digital therapeutics, with some showing a reduction in healthcare resource utilization rates for users compared to non-users.
There has been a rise in initiatives, such as suitable reimbursements, which are gaining traction and further increasing people's interest in the market. For instance, DTx companies rely on product adoption and reimbursements from healthcare payers to fully integrate digital therapeutics into mainstream healthcare. Although progress has been slow, the Digital Therapeutics Alliance has recently released a Digital Therapeutics Toolkit to guide the sector's growth and set evidence standards for these innovative solutions.
Global Digiceuticals Market Segmentations
Market Breakup by Type
- Software
- Devices
Market Breakup by Application
- Mental Health
- Chronic Disease Management
- Medication Adherence
- Others
Market Breakup by End User
- Hospital
- Specialty Clinics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Digiceuticals Market Overview
The market for mHealth applications is experiencing growth due to the rising number of smartphone users. This growth is further fuelled by the increasing prevalence of chronic diseases. According to the CDC's National Center for Chronic Disease Prevention and Health Promotion, 6 out of 10 American adults suffer from a chronic disease, with 4 out of 10 adults having two or more chronic diseases. The increasing prevalence of diabetes is also propelling the need to develop individualized solutions for treating diabetics, adding further growth to the global digiceuticals market share.
The COVID-19 pandemic has had a significant impact on the digital therapeutics market, leading to increased regulatory flexibility and greater access to digital health products. As a result, there has been a surge in demand for convenient and accessible digital health solutions intensifying the growth of the market.
Additionally, regulatory initiatives are expected to drive standardization and research and development in the market in the coming years, further boosting the market growth. An example of this is the Software Pre-Cert Pilot Program, which is part of the FDA's Digital Health Innovation Action Plan, designed to improve oversight of software-based medical devices developed by manufacturers.
The North American market is expected to maintain its leading position over the forecast period. The region is poised to experience a substantial surge in the market due to the implementation of favourable reimbursement scenarios aimed at improving tracking and diagnosis, as well as the increased adoption of digital health products that enhance quality of life.
Key players in the region are actively implementing strategic initiatives, such as launching new products and engaging in mergers and acquisitions, which will further fuel the growth of the market.
Global Digiceuticals Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pear Therapeutics
- Akili Interactive Labs
- Click Therapeutics
- Omada Health
- Happtique
- WellDoc
- Propeller Health (a subsidiary of ResMed)
- Canary Health, Inc.
- Glooko, Inc.
- 2Morrow
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digiceuticals Market Overview
3.1 Global Digiceuticals Market Historical Value (2017-2023)
3.2 Global Digiceuticals Market Forecast Value (2024-2032)
4 Global Digiceuticals Market Landscape
4.1 Global Digiceuticals: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digiceuticals: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Digiceuticals Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digiceuticals Market Segmentation
6.1 Global Digiceuticals Market by Type
6.1.1 Market Overview
6.1.2 Software
6.1.3 Devices
6.2 Global Digiceuticals Market by Application
6.2.1 Market Overview
6.2.2 Mental Health
6.2.3 Chronic Disease Management
6.2.4 Medication Adherence
6.2.5 Others
6.3 Global Digiceuticals Market by End User
6.3.1 Market Overview
6.3.2 Hospital
6.3.3 Specialty Clinics
6.4 Global Digiceuticals Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Digiceuticals Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Digiceuticals Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Digiceuticals Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Digiceuticals Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Digiceuticals Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Pear Therapeutics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Akili Interactive Labs
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Click Therapeutics
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Omada Health
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Happtique
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 WellDoc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Propeller Health (a subsidiary of ResMed)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Canary Health, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Glooko, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 2Morrow
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 6.10 billion in 2023, driven by the increasing technological development.
The market is anticipated to grow at a CAGR of 32.5% during the forecast period of 2024-2032, likely to reach a market value of USD 76.72 billion by 2032.
The increasing prevalence of chronic diseases and rising smartphone penetration in the market are the major factors driving the market growth.
The increasing technological development and rising collaborations between pharma and digiceutical companies are among the major trends influencing market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different types of digiceuticals include software and devices.
There are various applications for digiceuticals such as mental health, chronic disease management, and medication adherence, among others.
End users in the market are hospitals and specialty clinics.
Key players involved in the market are Pear Therapeutics, Akili Interactive Labs, Click Therapeutics, Omada Health, Happtique, WellDoc, Propeller Health (a subsidiary of ResMed), Canary Health, Inc., Glooko, Inc., and 2Morrow.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER